These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12633173)

  • 21. All-cause and cardiovascular mortality risk estimation using different definitions of metabolic syndrome in Lithuanian urban population.
    Luksiene D; Baceviciene M; Jureniene K; Bernotiene G; Reklaitiene R; Radisauskas R; Tamosiunas A
    Prev Med; 2012 Oct; 55(4):299-304. PubMed ID: 23046635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of metabolic syndrome].
    Nakamura T; Okauchi Y; Ryo M; Funahashi T; Shimomura I
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1731-6. PubMed ID: 17037307
    [No Abstract]   [Full Text] [Related]  

  • 23. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.
    Torchen LC
    Curr Diab Rep; 2017 Nov; 17(12):137. PubMed ID: 29128916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome.
    Bloomgarden ZT
    Diabetes Care; 2004 Mar; 27(3):824-30. PubMed ID: 14988311
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration.
    Fernandez-Mendoza J; He F; LaGrotte C; Vgontzas AN; Liao D; Bixler EO
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of metabolic syndrome on kidney transplantation outcomes: a systematic review and meta-analysis.
    Pedrollo EF; Corrêa C; Nicoletto BB; Manfro RC; Leitão CB; Souza GC; Gonçalves LF
    Transpl Int; 2016 Oct; 29(10):1059-66. PubMed ID: 27283100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome, depression, anxiety and mortality.
    Kawada T
    Int J Cardiol; 2015 Nov; 198():40-1. PubMed ID: 26151707
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metabolic syndrome, insulin resistance and cardiovascular disease in type-1 diabetes mellitus].
    Rodrigues TC; Canani LH; Gross JL
    Arq Bras Cardiol; 2010 Jan; 94(1):134-9. PubMed ID: 20414537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin.
    Abenavoli L; Milic N; Capasso F
    Endocrine; 2012 Dec; 42(3):754-5. PubMed ID: 22527892
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic Syndrome in Children and Adolescents: a Critical Approach Considering the Interaction between Pubertal Stage and Insulin Resistance.
    Reinehr T
    Curr Diab Rep; 2016 Jan; 16(1):8. PubMed ID: 26747052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of metabolic syndrome is not clear.
    Jarrett RJ
    BMJ; 2006 Apr; 332(7548):1036. PubMed ID: 16644848
    [No Abstract]   [Full Text] [Related]  

  • 33. Overactive bladder in men as a marker of cardiometabolic risk.
    Wittert GA; Martin S; Sutherland P; Hall S; Kupelian V; Araujo A
    Med J Aust; 2012 Oct; 197(7):379-80. PubMed ID: 23025729
    [No Abstract]   [Full Text] [Related]  

  • 34. Does the Additional Component of Calf Circumference Refine Metabolic Syndrome in Correlating With Cardiovascular Risk?
    Wu CJ; Kao TW; Chang YW; Peng TC; Wu LW; Yang HF; Chen WL
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1151-1160. PubMed ID: 29346655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome and the risk of thrombosis.
    Dentali F; Romualdi E; Ageno W
    Haematologica; 2007 Mar; 92(3):297-9. PubMed ID: 17339177
    [No Abstract]   [Full Text] [Related]  

  • 36. Why a cluster is truly a cluster: insulin resistance and cardiovascular disease.
    Reaven G
    Clin Chem; 2008 May; 54(5):785-7. PubMed ID: 18375479
    [No Abstract]   [Full Text] [Related]  

  • 37. [Metabolic syndrome and prostate cancer].
    Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C;
    Urologe A; 2013 Jun; 52(6):842-6. PubMed ID: 23494337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome in clinical practice.
    Katsiki N; Athyros VG; Karagiannis A
    Cardiol J; 2014; 21(2):209. PubMed ID: 24752952
    [No Abstract]   [Full Text] [Related]  

  • 39. Two (or more) sides of a coin.
    Beleigoli A; Diniz Mde F
    Heart; 2014 Sep; 100(18):1399-401. PubMed ID: 24916047
    [No Abstract]   [Full Text] [Related]  

  • 40. Does obesity make it better or worse: insights into cardiovascular illnesses.
    von Haehling S; Hartmann O; Anker SD
    Eur Heart J; 2013 Feb; 34(5):330-2. PubMed ID: 22947611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.